Kisspeptin Mitigates Hepatic De Novo Lipogenesis in Metabolic Dysfunction-Associated Steatotic Liver Disease.

This is a source-metadata record last found in a complete check on Sep 26, 2026. It is not a Pependium assessment of safety or effectiveness. Check the original sources for current details, corrections and full methods.

Source status: This saved record has not yet had a scheduled exact-ID status check. Check its original source links.

Study metadata

Study type: Original study
Study category (metadata hint): Other or unclear
Published: 2025-08-20
Authors: Izarraras K, Shah A, Prasad K, Tan H, Zhou Z, Bhattacharya M.
Journal or registry: Not reported
Registry study design: Not reported
Registry enrollment: Not reported
Funding agencies: Rutgers NJ Institute for Food Nutrition and Health S.D.G.; NCI NIH HHS; NIH HHS; Seed grant from the Rutgers NJ Institute for Food Nutrition and Health; NIDDK NIH HHS
Identifiers: DOI: 10.3390/cells14161289 · PMID: 40862768 · PMCID: PMC12384258
First found: Sep 26, 2026
Last found: Sep 26, 2026

Original sources

View at Europe PMC ↗